There is increasing evidence that gum disease is associated with an increased risk of cardiovascular events, including heart ...

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

The University of Virginia School of Medicine's Clint L. Miller, PhD, led the development of a new "atherosclerosis atlas" that details, at the level of individual cells, critical processes ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns. Fortunately, this ...

This study explores the role of methoxy polyethylene glycol@Elabela-11 (mPEG@ELA-11), a pH-responsive ELA-11 conjugate, in ...

Please provide your email address to receive an email when new articles are posted on . Researchers used AI to develop improved risk stratification tools for atherosclerotic CVD. The nomograms provide ...

More Than a "Lifeless Tube" Peter Libby, MD, [1] Harvard Medical School, Boston, Massachusetts, discussed the biology of the atheromatous plaque, contrasting the traditional view of the artery wall as ...

A pioneering study led by researchers from Tongji University School of Medicine, Shanghai Jiao Tong University School of ...

Over a century of epidemiologic studies and randomized trials have definitively established the causal role of cholesterol in the development of atherosclerosis. Total cholesterol, and later ...